Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE15913
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM399720
GPL570
CLL patient 01, untreated peripheral blood derived sample of CLL patient 01 prior to therapy treatment response: complete response (CR) wbc change: -5.9 treg fold change: -2.724969843 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 01 before thalidomide treament
GSM399721
GPL570
CLL patient 02, untreated peripheral blood derived sample of CLL patient 02 prior to therapy treatment response: partial response (PR) wbc change: 27.2 treg fold change: -5.151223776 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 02 before thalidomide treament
GSM399722
GPL570
CLL patient 03, untreated peripheral blood derived sample of CLL patient 03 prior to therapy treatment response: complete response (CR) wbc change: -2.7 treg fold change: -1.55654102 flare reaction: yes deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 03 before thalidomide treament
GSM399723
GPL570
CLL patient 04, untreated peripheral blood derived sample of CLL patient 04 prior to therapy treatment response: no response (NR) wbc change: -114 treg fold change: -2.881040892 flare reaction: no deletion 17p13: yes deletion 11q22-q23: no Gene expression data from CLL patient 04 before thalidomide treament
GSM399724
GPL570
CLL patient 05, untreated peripheral blood derived sample of CLL patient 05 prior to therapy treatment response: no response (NR) wbc change: -1.1 treg fold change: NA flare reaction: yes deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 05 before thalidomide treament
GSM399725
GPL570
CLL patient 06, untreated peripheral blood derived sample of CLL patient 06 prior to therapy treatment response: no response (NR) wbc change: 36.1 treg fold change: -19.38718663 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 06 before thalidomide treament
GSM399726
GPL570
CLL patient 07, untreated peripheral blood derived sample of CLL patient 07 prior to therapy treatment response: no response (NR) wbc change: -30 treg fold change: -1.127659574 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 07 before thalidomide treament
GSM399727
GPL570
CLL patient 08, untreated peripheral blood derived sample of CLL patient 08 prior to therapy treatment response: partial response (PR) wbc change: 12.5 treg fold change: NA flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 08 before thalidomide treament
GSM399728
GPL570
CLL patient 09, untreated peripheral blood derived sample of CLL patient 09 prior to therapy treatment response: partial response (PR) wbc change: -34.1 treg fold change: -2.258333333 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 09 before thalidomide treament
GSM399729
GPL570
CLL patient 10, untreated peripheral blood derived sample of CLL patient 10 prior to therapy treatment response: partial response (PR) wbc change: 45.5 treg fold change: 1.047817048 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 10 before thalidomide treament
GSM399730
GPL570
CLL patient 11, untreated peripheral blood derived sample of CLL patient 11 prior to therapy treatment response: partial response (PR) wbc change: 28.1 treg fold change: 1.662262156 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 11 before thalidomide treament
GSM399731
GPL570
CLL patient 12, untreated peripheral blood derived sample of CLL patient 12 prior to therapy treatment response: partial response (PR) wbc change: 0.2 treg fold change: -1.916092298 flare reaction: yes deletion 17p13: yes deletion 11q22-q23: yes Gene expression data from CLL patient 12 before thalidomide treament
GSM399732
GPL570
CLL patient 13, untreated peripheral blood derived sample of CLL patient 13prior to therapy treatment response: no response (NR) wbc change: 45.3 treg fold change: NA flare reaction: yes deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 13 before thalidomide treament
GSM399733
GPL570
CLL patient 14, untreated peripheral blood derived sample of CLL patient 14 prior to therapy treatment response: partial response (PR) wbc change: 29.5 treg fold change: -2.34375 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 14 before thalidomide treament
GSM399734
GPL570
CLL patient 15, untreated peripheral blood derived sample of CLL patient 15 prior to therapy treatment response: no response (NR) wbc change: 6.5 treg fold change: -2.010775862 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 15 before thalidomide treament
GSM399735
GPL570
CLL patient 16, untreated peripheral blood derived sample of CLL patient 16 prior to therapy treatment response: no response (NR) wbc change: 2.2 treg fold change: 2.021857923 flare reaction: no deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 16 before thalidomide treament
GSM399736
GPL570
CLL patient 17, untreated peripheral blood derived sample of CLL patient 17prior to therapy treatment response: no response (NR) wbc change: -3.5 treg fold change: 1.028861789 flare reaction: yes deletion 17p13: yes deletion 11q22-q23: no Gene expression data from CLL patient 17 before thalidomide treament
GSM399737
GPL570
CLL patient 18, untreated peripheral blood derived sample of CLL patient 18 prior to therapy treatment response: complete response (CR) wbc change: 20.2 treg fold change: -2.438202247 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 18 before thalidomide treament
GSM399738
GPL570
CLL patient 19, untreated peripheral blood derived sample of CLL patient 19 prior to therapy treatment response: partial response (PR) wbc change: 10.2 treg fold change: -2.051674641 flare reaction: no deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 19 before thalidomide treament
GSM399739
GPL570
CLL patient 20, untreated peripheral blood derived sample of CLL patient 20 prior to therapy treatment response: no response (NR) wbc change: 2.9 treg fold change: -1.336082474 flare reaction: no deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 20 before thalidomide treament
GSM399740
GPL570
CLL patient 01, thalidomide treated peripheral blood derived sample of CLL patient 01 past thalidomide therapy treatment response: complete response (CR) wbc change: -5.9 treg fold change: -2.724969843 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 01 following 7 days of thalidomide treament
GSM399741
GPL570
CLL patient 02, thalidomide treated peripheral blood derived sample of CLL patient 02 past thalidomide therapy treatment response: partial response (PR) wbc change: 27.2 treg fold change: -5.151223776 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 02 following 7 days of thalidomide treament
GSM399742
GPL570
CLL patient 03, thalidomide treated peripheral blood derived sample of CLL patient 03 past thalidomide therapy treatment response: complete response (CR) wbc change: -2.7 treg fold change: -1.55654102 flare reaction: yes deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 03 following 7 days of thalidomide treament
GSM399743
GPL570
CLL patient 04, thalidomide treated peripheral blood derived sample of CLL patient 04 past thalidomide therapy treatment response: no response (NR) wbc change: -114 treg fold change: -2.881040892 flare reaction: no deletion 17p13: yes deletion 11q22-q23: no Gene expression data from CLL patient 04 following 7 days of thalidomide treament
GSM399744
GPL570
CLL patient 05, thalidomide treated peripheral blood derived sample of CLL patient 05 past thalidomide therapy treatment response: no response (NR) wbc change: -1.1 treg fold change: NA flare reaction: yes deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 05 following 7 days of thalidomide treament
GSM399745
GPL570
CLL patient 06, thalidomide treated peripheral blood derived sample of CLL patient 06 past thalidomide therapy treatment response: no response (NR) wbc change: 36.1 treg fold change: -19.38718663 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 06 following 7 days of thalidomide treament
GSM399746
GPL570
CLL patient 07, thalidomide treated peripheral blood derived sample of CLL patient 07 past thalidomide therapy treatment response: no response (NR) wbc change: -30 treg fold change: -1.127659574 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 07 following 7 days of thalidomide treament
GSM399747
GPL570
CLL patient 08, thalidomide treated peripheral blood derived sample of CLL patient 08 past thalidomide therapy treatment response: partial response (PR) wbc change: 12.5 treg fold change: NA flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 08 following 7 days of thalidomide treament
GSM399748
GPL570
CLL patient 09, thalidomide treated peripheral blood derived sample of CLL patient 09 past thalidomide therapy treatment response: partial response (PR) wbc change: -34.1 treg fold change: -2.258333333 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 09 following 7 days of thalidomide treament
GSM399749
GPL570
CLL patient 10, thalidomide treated peripheral blood derived sample of CLL patient 10 past thalidomide therapy treatment response: partial response (PR) wbc change: 45.5 treg fold change: 1.047817048 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 10 following 7 days of thalidomide treament
GSM399750
GPL570
CLL patient 11, thalidomide treated peripheral blood derived sample of CLL patient 11 past thalidomide therapy treatment response: partial response (PR) wbc change: 28.1 treg fold change: 1.662262156 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 11 following 7 days of thalidomide treament
GSM399751
GPL570
CLL patient 12, thalidomide treated peripheral blood derived sample of CLL patient 12 past thalidomide therapy treatment response: partial response (PR) wbc change: 0.2 treg fold change: -1.916092298 flare reaction: yes deletion 17p13: yes deletion 11q22-q23: yes Gene expression data from CLL patient 12 following 7 days of thalidomide treament
GSM399752
GPL570
CLL patient 13, thalidomide treated peripheral blood derived sample of CLL patient 13past thalidomide therapy treatment response: no response (NR) wbc change: 45.3 treg fold change: NA flare reaction: yes deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 13 following 7 days of thalidomide treament
GSM399753
GPL570
CLL patient 14, thalidomide treated peripheral blood derived sample of CLL patient 14 past thalidomide therapy treatment response: partial response (PR) wbc change: 29.5 treg fold change: -2.34375 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 14 following 7 days of thalidomide treament
GSM399754
GPL570
CLL patient 15, thalidomide treated peripheral blood derived sample of CLL patient 15 past thalidomide therapy treatment response: no response (NR) wbc change: 6.5 treg fold change: -2.010775862 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 15 following 7 days of thalidomide treament
GSM399755
GPL570
CLL patient 16, thalidomide treated peripheral blood derived sample of CLL patient 16 past thalidomide therapy treatment response: no response (NR) wbc change: 2.2 treg fold change: 2.021857923 flare reaction: no deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 16 following 7 days of thalidomide treament
GSM399756
GPL570
CLL patient 17, thalidomide treated peripheral blood derived sample of CLL patient 17past thalidomide therapy treatment response: no response (NR) wbc change: -3.5 treg fold change: 1.028861789 flare reaction: yes deletion 17p13: yes deletion 11q22-q23: no Gene expression data from CLL patient 17 following 7 days of thalidomide treament
GSM399757
GPL570
CLL patient 18, thalidomide treated peripheral blood derived sample of CLL patient 18 past thalidomide therapy treatment response: complete response (CR) wbc change: 20.2 treg fold change: -2.438202247 flare reaction: no deletion 17p13: no deletion 11q22-q23: no Gene expression data from CLL patient 18 following 7 days of thalidomide treament
GSM399758
GPL570
CLL patient 19, thalidomide treated peripheral blood derived sample of CLL patient 19 past thalidomide therapy treatment response: partial response (PR) wbc change: 10.2 treg fold change: -2.051674641 flare reaction: no deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 19 following 7 days of thalidomide treament
GSM399759
GPL570
CLL patient 20, thalidomide treated peripheral blood derived sample of CLL patient 20 past thalidomide therapy treatment response: no response (NR) wbc change: 2.9 treg fold change: -1.336082474 flare reaction: no deletion 17p13: no deletion 11q22-q23: yes Gene expression data from CLL patient 20 following 7 days of thalidomide treament
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes